Skin Drug Delivery: Transdermal & Microneedles
Issue No #84
March 19th, 2018
Inside the magazine
Dr Jung Dong Kim
DISSOLVABLE MICRONEEDLES: APPLICATIONS AND OPPORTUNITIES
Jung Dong Kim and Do Hyeon Jeong discuss dissolvable microneedle technology and its myriad uses.
Dr Aparajita Khatri
SILICA NANO-SOLUTIONS FOR SKIN DELIVERY
Aparajita Khatri and Christophe A Barbé outline the growth of the dermal delivery market, as well as the challenges it faces. The authors go on to detail a nanocomposite lidocaine patch.
Dr Moe Wehbe
AN INTRADERMAL PLATFORM BUILT FOR INDUSTRY AND PATIENTS
Moe Wehbe, Iman Mansoor and Sahan Ranamukha discuss the potential of intradermal injection for modern medicines and its advantages over the subcutaneous route.
Dr Mark Prausnitz
SIMPLIFIED DRUG AND VACCINE DELIVERY USING MICRON’S MICRONEEDLE PATCH
Devin V McAllister, Sebastien Henry and Mark Prausnitz introduce the company’s dissolving microneedle patch technology, which has global potential, including in the developing world, across a range of vaccine and therapeutic applications.
Prof Marc Brown
COST-EFFECTIVE APPROACHES FOR SUCCESSFUL GENERIC DERMAL DRUG PRODUCT AUTHORISATIONS
Marc Brown, Jon Lenn and Jeremy Dummond discuss various methods and advantages of
bioequivalence studies for topical skin application, and how MedPharm’s unique technologies and experience can be invaluable in the effective development of generics in this field.
QUALITY BY DESIGN IN TDS DEVELOPMENT: BENEFIT OR BUREAUCRATIC BURDEN?
Petra Botzem and Thomas Hille discuss the Quality-by-Design approach to the development of transdermal drug delivery systems as laid out in ICH guideline Q8.
Dr Faz Chowhury
TERIPARATIDE MICRO-PATCH™: A SOLID MICRONEEDLE PRODUCT NEARING CLINICAL TRIALS
Faz Chowdhury details a Micro-Patch™ solid formulation of the parathyroid hormone analogue, teriparatide, for the treatment of osteoporosis.
This website uses functional cookies (but not advertising cookies). View our
Privacy & Cookies Policy